Grid Oasis
Pricing
Sign in
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

OCGN

+ Watchlist+ Portfolio

Ocugen, Inc.

GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Market Snapshot

Dow Jones
S&P 500
NASDAQ 100
Russell 2000

About

Ocugen, Inc. is a biotechnology company developing gene therapies and cell therapies to cure blindness and treat eye diseases including inherited retinal diseases.